deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT01183637

Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions Pilot Trial (EAGLE Pilot)

Initial Safety and Effectiveness Study of the Kensey Nash Corp. Cartilage Repair Device for Knee Cartilage Lesion Repair

Sponsor: Kensey Nash Corporation

Updated 8 times since 2017 Last updated: May 7, 2015 Started: Jun 30, 2010 Primary completion: Dec 31, 2013 Completion: May 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study enrollment rate was far slower than anticipated. Study was stopped for business purposes.

Other terminated trials from Kensey Nash Corporation

More terminations from Kensey Nash Corporation

Listed as NCT01183637, this PHASE2 trial focuses on Articular Cartilage Injury and remains terminated or withdrawn. Sponsored by Kensey Nash Corporation, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotTerminated~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotTerminated~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Apr 2022 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Apr 2022 [monthly]

    Terminated PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

Show 3 earlier versions
  1. Aug 2017 — Jun 2018 [monthly]

    Terminated PHASE2

  2. Feb 2017 — Aug 2017 [monthly]

    Terminated PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kensey Nash Corporation
Data source: Kensey Nash Corporation

For direct contact, visit the study record on ClinicalTrials.gov .